Global Cancer Drug Delivery Technologies, Markets and

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
25
Global Cancer Drug Delivery Technologies, Markets and Companies Research Report 2017 - Projections to 2026

Dublin, Oct. 05, 2017 (GLOBE NEWSWIRE) -- The "Drug Delivery in Cancer - Technologies, Markets and Companies" report from Jain PharmaBiotech has been added to Research and Markets' offering.

Drug delivery remains a challenge in management of cancer. Approximately 12.5 million new cases of cancer are being diagnosed worldwide each year and considerable research is in progress for drug discovery for cancer. Cancer drug delivery is no longer simply wrapping up cancer drugs in a new formulations for different routes of delivery. The focus is on targeted cancer therapy. The newer approaches to cancer treatment not only supplement the conventional chemotherapy and radiotherapy but also prevent damage to normal tissues and prevent drug resistance.

Innovative cancer therapies are based on current concepts of molecular biology of cancer. These include antiangiogenic agents, immunotherapy, bacterial agents, viral oncolysis, targeting of cyclic-dependent kinases and tyrosine kinase receptors, antisense approaches, gene therapy and combination of various methods. Important methods of immunotherapy in cancer involve use of cytokines, monoclonal antibodies, cancer vaccines and immunogene therapy.

Several innovative methods of drug delivery are used in cancer. These include use of microparticles as carriers of anticancer agents. These may be injected into the arterial circulation and guided to the tumor by magnetic field for targeted drug delivery. Polyethylene glycol (PEG) technology has been used to overcome some of the barriers to anticancer drug delivery. Encapsulating anticancer drugs in liposomes enables targeted drug delivery to tumor tissues and prevents damage to the normal surrounding tissues. Monoclonal antibodies can be used for the delivery of anticancer payloads such as radionucleotides, toxins and chemotherapeutic agents to the tumors.

Antisense oligonucleotides have been in clinical trials for cancer for some time now. RNAi has also been applied in oncology. Small interfering RNAs (siRNAs) can be targeted to tumors and one example is suppression of H-ras gene expression indicating the potential for application in therapy of ovarian cancer. Cancer gene therapy is a sophisticated form of drug delivery for cancer. Various technologies and companies developing them are described. Nucleic acid-based cancer vaccines are also described.

Drug delivery strategies vary according to the type and location of cancer. Role of drug delivery in the management of cancers of the brain, the bladder, the breast, the ovaries and the prostate are used as examples to illustrate different approaches both experimental and clinical. Biodegradable implants of carmustine are already used in the treatment of malignant brain tumors.

The market value of drug delivery technologies and the anticancer drugs are difficult to separate. Cancer market estimates from 2016-2026 are given according to organs involved and the types of cancer as well as according to technologies. Distribution of the into major regions is also described.

Profiles of 234 companies involved in developing innovative cancer therapies and methods of delivery are presented along with their 278 collaborations. The bibliography contains over 650 publications that are cited in the report.The report is supplemented with 65 tables and 13 figures.

Key Topics Covered:

Part I: Technologies & Markets Executive Summary 1. Introduction to cancer therapy 2. Innovative treatments for cancer 3. Drug delivery systems for cancer 4. Delivery of Biological Therapies for Cancer 5. Delivery strategies according to cancer type and location 6. Cancer drug delivery markets 7. References Part II: Companies

8. Companies involved in cancer drug delivery

For more information about this report visit https://www.researchandmarkets.com/research/q...elivery_in

CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 Related Topics: Drug Delivery, Oncology Drugs

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sinopec Unveils Biodiversity Report at COP17

Updated Category News Views 47

Sinopec's First Step on the Global Biodiversity Stage Seems like Sinopec (HKG: 0386) has decided to toss its hat into the biodiversity conservation ring. At COP17 in Armenia, they released their inaugural Global Biodiversity Conservation Report—an event that marks more than just a company selling oil and gas. Now, they're talking wildlife and ecologies. Is that irony,...

Continue Reading
Veteran Surge in 2026 Midterm Elections: A New Wave

Updated Category News Views 43

A Swell of Veteran Candidates Hits the Midterm Shores Just when you think you've seen it all in politics, here comes another twist. As the 2026 midterms gear up, an impressive 258 military veterans are throwing their hats into the congressional ring. That's a jump up from 213 just two years back, and let me tell you, it's not just a numbers game—it's a sea change. Women...

Continue Reading
HIZENERGY Sustains Tier 1 Status Amid Tighter Criteria

Updated Category News Views 90

Another Feather in HIZENERGY's Cap In a landscape where credibility can make or break a business, HIZENERGY has once again staked its claim as a powerhouse. Come Q4 2026, and despite a rougher sea to navigate with BloombergNEF’s (BNEF) upgraded Tier 1 criteria, the company held its own. For those unacquainted, securing a place on this lofty list involves some serious...

Continue Reading
New Era Celebrates Valkyries' Groundbreaking WNBA Win

Updated Category News Views 217

A Surprising Win for a Rising Team In the world of sports, sometimes the odds are defied, and stories of triumph unfold that capture the imagination. The Golden State Valkyries did exactly that by snagging their first WNBA Championship title just a year after entering the league. It's a narrative right out of a Hollywood script—only this time, it's inked in real...

Continue Reading
ENGWE Unleashes Massive Black Friday E-Bike Discounts

Updated Category News Views 70

ENGWE Powers Up the 2026 Black Friday Storm If you’ve ever been on the hunt for a reliable e-bike, ENGWE is making a racket that’ll be impossible to ignore this Black Friday. Starting November 2nd and running up to December 3rd, they’re throwing down the gauntlet with some jaw-dropping deals across their line-up. Now, why should you care? For starters, they’ve...

Continue Reading
Cleafy's Cyber-Fraud Edge in SPARK Matrix™ 2026

Updated Category News Views 0

What's Cookin'? Cleafy Leads in Fraud Management Lineup Eying the world through a prism of calculated risk and opportunity, Cleafy has emerged a big dog in the latest QKS Group SPARK Matrix™ for Enterprise Fraud Management, 2026. The spotlight's on their cutting-edge knack for dodging cyber fraud's punches, a distinction that hints at a deeper market shift for those who...

Continue Reading
Perion Acquisition: Affle's Bold Leap in Ad Tech

Updated Category News Views 228

Affle's Strategic Acquisition of Perion Jumpin' through another hoop, Affle is gearing up to snag Perion in a hefty deal valued at about $420 million. For those of you not knee-deep in the ad tech sandbox, Affle—trading on the NSE as AFFLE—is aiming to ramp up its AI-driven conversion game by absorbing Perion, a veteran in the omnichannel advertising realm. "This...

Continue Reading
Isinwheel's 2027 E-Mobility Pitch: Beyond Resolutions

Updated Category News Views 163

Embracing the E-Mobility Shift Here we are at the tail end of 2026, and isinwheel is riding high on the wave of New Year resolutions with their hefty e-mobility lineup. It's not just about buying the gear—it's about tackling our reliance on gas-guzzlers with electric scooters and bikes as our trusty steeds. "Reduce car trips? More greenery in your commute? These aren't...

Continue Reading
Stellantis Harnesses AI for Customer Connection Boost

Updated Category News Views 0

Trading Mayhem: Pre-Market Vibes Ever put your ear to the ground on the NYSE floor and felt that buzz of untamed optimism clashing with skepticism? Today it's all about connections, from the data-driven to the familial. Imagine Stellantis (NYSE: STLA) is making a play, aligning with Amperity in an ambitious attempt to make customer interactions feel more personal. Now,...

Continue Reading
RD Technologies Ramps Up Cross-Border Payments

Updated Category News Views 160

RD Technologies: Revving Up the Payment Game RD Technologies is at it again, jazzing up its game in the cross-border payments realm. One can almost smell the digits doing a tango across continents—particularly as Hong Kong's financial warriors set their sights on beefing up trade between Africa and Asia. New Alliances in the Payment Arena Here's a roadmap: Connect the...

Continue Reading

Top 5 Most Recently Viewed Articles

Rural Healthcare Transformation: Data-Driven Innovations in Practice

Updated Category News Views 234

Revolutionizing Rural Healthcare with Data-Driven Solutions REDi Health Analytics, LLC ("REDi Health") has forged a partnership with a state health department to significantly boost the data capacity of six rural hospitals. Their goal is to enhance healthcare delivery and bridge the health disparities prevalent in rural communities. As highlighted by John Wadsworth,...

Continue Reading
Boeing Charges Union with Unfair Labor Practices Amid Strikes

Updated Category News Views 194

Boeing Takes Action Against Striking Union Boeing, a leading name in aerospace manufacturing, has recently initiated a charge of unfair labor practices against the union representing approximately 33,000 West Coast factory workers. This action highlights the ongoing tensions amid the strike that has disrupted operations. Allegations of Bad Faith Bargaining The charge was...

Continue Reading
Deckers Outdoor Adjusts to Split with New Price Target Set

Updated Category News Views 58

Deckers Outdoor Stock Price Target Update Recently, Evercore ISI made headlines by revising its price target for the shares of Deckers Outdoor (NYSE: DECK), adjusting it down to $183 from the previous level of $1,100. This reduction, while significant, comes after the company undertook a 6-for-1 stock split, a move aimed at making the stock more appealing to investors....

Continue Reading
Beam Therapeutics Welcomes Sravan Emany as New CFO

Updated Category News Views 247

Beam Therapeutics Welcomes a New Chief Financial Officer Beam Therapeutics Inc. (Nasdaq: BEAM), a leader in developing precision genetic medicines, is heralding an important new chapter in its journey with the appointment of Sravan K. Emany as its Chief Financial Officer (CFO). Bringing vast experience from his previous roles in well-established corporations, Mr. Emany is...

Continue Reading
Keysight Technologies Partners with UL Solutions for Certification

Updated Category News Views 192

Keysight Technologies, Inc. (NYSE: KEYS) made headlines by securing its role as a test partner for Thunderbolt 5 certification back in 2024. This partnership with UL Solutions is no small feat—it's a strategic play that puts Keysight squarely in the fast lane of advanced connectivity. As the landscape shifts, this collaboration hints at what’s coming: faster speeds...

Continue Reading